---
$id: https://graph.org.ai/products/commodity/51282951
$type: Product
source: UNSPSC
code: "51282951"
title: "Nalidixic acid"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nalidixic acid

**UNSPSC Code**: 51282951
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula C12H12N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3B91HWA56M, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo- but generally known as nalidixic acid, which bears US NIH Compound Identifier 4421. European Medicines Agency schedules Nalidixic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09138MIG. The term NALIDIXIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules nalidixic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule nalidixic acid under HS 29339990 and SITC 51577. As of Q4 2014, NALIDIXIC ACID remains the US FDA Preferred Term for this commodity. Nalidixic acid bears US NLM identifiers UMLS ID C0027353 and NCI Concept Code C47630. SMILES: CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O.

